Litcius/Paper detail

Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer

Carol C. Cheung, Adam C. Smith, Roula Albadine, Gilbert Bigras, Anna Bojarski, Christian Couture, Jean‐Claude Cutz, Weei‐Yuan Huang, Diana N. Ionescu, Doha Itani, Iyare Izevbaye, Aly Karsan, Margaret M. Kelly, Joan H.M. Knoll, Keith Kwan, Michel R. Nasr, Gefei Qing, Fariboz Rashid-Kolvear, Harmanjatinder S. Sekhon, Alan Spatz, Tracy Stockley, Danh Tran‐Thanh, Tracy Tucker, Ranjit Waghray, Hangjun Wang, Zhaolin Xu, Yasushi Yatabe, Emina Torlakovic, Ming‐Sound Tsao

2021Lung Cancer22 citationsDOI

Topics & Concepts

ROS1ImmunohistochemistryMedicineCrizotinibLung cancerFluorescence in situ hybridizationCancer researchPathologyCancerOncogeneAdenocarcinomaInternal medicineBiologyGeneCell cycleGeneticsChromosomeMalignant pleural effusionLung Cancer Treatments and MutationsCancer Genomics and DiagnosticsLung Cancer Diagnosis and Treatment
Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer | Litcius